title: Phosphodiesterase inhibitors and forskolin Up-regulate arginase activity in rabbit alveolar macrophages.
abstract: Alveolar macrophages (AMsmall ef, Cyrillic) express considerable arginase activity which can be modulated by various mediators. As inhibitors of phosphodiesterase (PDE) play an increasing role in the treatment of chronic inflammatory and obstructive airway disease, we tested whether PDE inhibitors affect arginase activity in AMsmall ef, Cyrillic. Isolated rabbit AMsmall ef, Cyrillic were cultured for 20 h in the absence or presence of bacterial lipopolysaccharides (LPS) and/or different test substances. Thereafter arginase activity was determined by measuring the formation of [(3)H]-L-ornithine during 1 h incubation with [(3)H]-L-arginine. Lipopolysaccharide-enhanced (0. 01-5 microg/ml) maximal arginase activity by about 2.5-fold. The non-selective PDE inhibitor IBMX and the PDE4 selective inhibitor rolipram (each up to 30 microM) caused a 2.4-fold increase in arginase activity, and these effects were additive to those of LPS. The PDE3-selective inhibitor siguazodan had only marginal effects. Forskolin (10 microM) also enhanced arginase activity in the absence and presence of LPS. The effect of forskolin was almost prevented by cycloheximide (30 microM) and largely attenuated by the protein kinase A inhibitor KT 5720 (300 nM). In conclusion, inhibition of the cAMP-specific PDE4, like direct activation of adenylyl cyclase, causes an up-regulation of arginase activity in rabbit AMsmall ef, Cyrillic.
authors.affiliation: Institute of Pharmacology and Toxicology, University of Bonn, Reuterstr. 2b, Bonn, D-53113, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Hammermann
authors.forename: C
authors.initials: C
authors.lastname: Hey
authors.forename: N
authors.initials: N
authors.lastname: Schäfer
authors.forename: K
authors.initials: K
authors.lastname: Racké
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D001119:Arginase / Q000096:biosynthesis*; D005576:Colforsin / Q000494:pharmacology*; D005260:Female; D007527:Isoenzymes / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D016676:Macrophages, Alveolar / Q000201:enzymology*; D008297:Male; D009952:Ornithine / Q000096:biosynthesis; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011817:Rabbits; D015854:Up-Regulation
chemical_list: D007527:Isoenzymes; D008070:Lipopolysaccharides; D010726:Phosphodiesterase Inhibitors; D005576:Colforsin; D009952:Ornithine; D010727:Phosphoric Diester Hydrolases; D001119:Arginase; D015056:1-Methyl-3-isobutylxanthine